Cross-over Study to Prove Bioequivalence Between Two Oral Formulations of Levonorgestrel 1.5 mg

NCT01073904 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Contraceptives, Postcoital

Interventions

DRUG: Levonorgestrel Emergency Pill (BAY86-5028)
DRUG: Postinor 2

Sponsor

Bayer